Hyperbilirubinemia and Gilbert's syndrome in Cystic Fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor

J Cyst Fibros. 2023 Nov;22(6):1130-1132. doi: 10.1016/j.jcf.2023.06.013. Epub 2023 Jul 1.

¹ Department of Paediatric Medicine, Cystic Fibrosis Regional Reference Center, Meyer Children's Hospital IRCCS, Florence, Italy. Electronic address: vito.terlizzi@meyer.it.
² Cystic Fibrosis Regional Support Center, Department of Pediatrics, ASST Spedali Civili Brescia, University of Brescia, Brescia, Italy.
³ Paediatric Unit, Department of Maternal and Child health, Cystic Fibrosis Regional Reference Center, University of Naples Federico II, Naples, Italy.
⁴ Paediatric Unit, Department of Translational Medical Sciences, Cystic Fibrosis Regional Reference Center, University of Naples Federico II, Naples, Italy.
⁵ Department of Paediatric Medicine, Cystic Fibrosis Regional Reference Center, Meyer Children's Hospital IRCCS, Florence, Italy.
⁶ Cystic Fibrosis Regional Reference Center, Azienda Universitaria Ospedaliera Consorziale Policlinico, Bari, Italy.
⁷ Cystic Fibrosis Support Center, Ospedale G. Tatarella di Cerignola, Cerignola, Italy.
⁸ Cystic Fibrosis Center, Hospital San Carlo, Potenza, Italy.

No abstract available

Publication types